Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.